Information, deadlines and resource documents for U.S. tariff actions and the responses by the rest of the world.
Internationally recognized trade compliance training.
Subscribe to daily updates
The Drug Enforcement Administration has issued a final order that temporarily schedules the opioid MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine), including its salts, isomers, and salts of isomers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. MT-45 is an opioid analgesic drug with pharmacological effects similar to morphine.
As a result, this substance will be subject to the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess, MT-45. This order is effective Jan. 12, 2018, and will be in effect for two years, with a possible extension of one year, pending completion of the permanent scheduling process.
September 21, 2020 // Trade Report
September 10, 2020 // Trade Report
September 4, 2020 // Trade Report
August 17, 2020 // Trade Report